Digital Payer Portals for Enhanced Value Communication
The trend of using digital tools for communication and information sharing in the life science…
CertaraAugust 9, 2024
The Scary Future of Rare Disease Management
In a world of rising healthcare costs, the greatest nightmare for payers is reimbursing drug…
CertaraSeptember 23, 2021
Succeeding in Value Communication: Introduction
Drawn from the experiences of the BaseCase Consulting Team, this is the introduction to ‘Succeeding…
CertaraAugust 5, 2021
What is BaseCase?
Developing interactive and easy-to-use stakeholder engagement content market access, medical affairs, and sales field teams…
CertaraJuly 20, 2021
Preparing for High Stakes Meetings; How to Best Convey a New Drug’s Value to Payers
This blog post includes key takeaways from the opening session of Certara’s first Strategic Evidence…
CertaraJune 18, 2021
Three Pathways have emerged in Innovative Access Agreements
The days of simply determining the market demand for a new drug as a function…
CertaraJune 11, 2021
Outcomes Based Agreements
The days of simply determining the market demand for a new drug as a function…
CertaraJune 11, 2021
Stakeholder perspectives: current and potential benefits
Amongst the real world data sources in Europe, the French Healthcare database SNDS is the…
CertaraMay 26, 2021
Strengths and opportunities for HTAs and market access in Europe through case studies
Amongst the real world data sources in Europe, the French Healthcare database SNDS is the…
CertaraMay 26, 2021
